A growing body of evidence indicates that the anticancer effect of the immune system can be
activated by the immunogenic modulation of dying cancer cells. Cancer cell death, as a …

Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast
cancer. Radiation therapy (RT) is a modality for TNBC management. Radiosensitizers can …

Chemotherapy, radiotherapy, targeted therapy, and immunotherapy are established cancer
treatment modalities that are widely used due to their demonstrated efficacy against tumors …

Background Prostate cancer is among the most common cancers in men with an increasing
incidence rate. Radiation therapy (RT) is a therapeutic strategy for the management of …

Background Despite aggressive local and regional therapy, triple-negative breast cancer
(TNBC) is characterized by an increased risk of locoregional recurrence. RNA-sequencing …

Breast cancer stem cells (BCSCs) are a small subpopulation of breast cancer cells, capable
of metastasis, recurrence, and drug resistance in breast cancer patients. Therefore, targeting …

Induction of immunogenic cell death (ICD) is a promising strategy for cancer
immunotherapy. Chrysin, which has potential anticancer effects, faces limitations in clinical …

Chrysin is a natural flavonoid with anti-cancer effects. Despite its beneficial effects, little
information is available regarding its immunogenic cell death (ICD) properties. In this work …

Introduction Chrysin has a wide range of biological activities, but its poor bioavailability
greatly limits its use. Here, we attempted to prepare casein (cas)-based nanoparticles to …

Background The discovery of novel cancer therapeutic strategies leads to the development
of nanotechnology-based methods for cancer treatment. Silver nanoparticles (Ag-NPs) have …